Cited by 5,204Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDiet and metabolism studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Early Identification of Refractory Epilepsy

Open access

Kwan, Patrick, Brodie, Martin J.·2000·New England Journal of Medicine

DOI 10.1056/nejm200002033420503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.

Integrity signals

Registry

Crossref · 10.1056/nejm200002033420503

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Proposal for Revised Classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy
(1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05316.x · Cited by 5,347
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Surgery for Seizures
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citation
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation

Show all 39 references

Research works printed but not linked: 2

Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.

Sorted by citations

Items 801–900 of 1,005

Applications of OPM-MEG for translational neuroscience: a perspective
Brickwedde, M., Anders, P., Kühn, A. A., Lofredi, R., Holtkamp, M., Kaindl, A. M., Grent-‘t-Jong, T., Krüger, P., Sander, T. H., & Uhlhaas, P. J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03047-y · Cited by 59
The role of high-frequency oscillations in epilepsy surgery planning
Gloss, D. S., Nevitt, S. J., & Staba, R. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010235.pub3 · Cited by 57
A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures
Biton, V., Krauss, G. L., Vasquez‐Santana, B., Bibbiani, F., Mann, A., Perdomo, C. A., & Narurkar, M. M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02729.x · Cited by 57
Tolerability of antiseizure medications
Gilliam, F. G., Carter, J., & Vahle, V. J. (2004) · Neurology · doi:10.1212/wnl.63.10_suppl_4.s9 · Cited by 57
Clinical issues in considering vagus nerve stimulation for treatment-resistant depression
Rush, A. J., & Siefert, S. E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.015 · Cited by 58
The Source of Afterdischarge Activity in Neocortical Tonic–Clonic Epilepsy
Trevelyan, A. J., Baldeweg, T., van Drongelen, W., Yuste, R., & Whittington, M. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3005-07.2007 · Cited by 58
Neuronal MDR-1 Gene Expression and Persistent Low Levels of Anticonvulsants in a Child with Refractory Epilepsy
Lazarowski, A., Massaro, M., Schteinschnaider, Á., Intruvini, S., Sevlever, G. E., & Rabinowicz, A. L. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200402000-00010 · Cited by 57
A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy
Guerrini, R., Rosati, A., Segieth, J., Pellacani, S., Bradshaw, K., & Giorgi, L. (2013) · Epilepsia · doi:10.1111/epi.12233 · Cited by 57
Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety
Kothare, S. V., & Kaleyias, J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.493 · Cited by 57
Characterization and preliminary anticonvulsant assessment of some 1,3,4-thiadiazole derivatives
Łuszczki, J. J., Karpińska, M. M., Matysiak, J., & Niewiadomy, A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.008 · Cited by 57
Seizures in children with dysembryoplastic neuroepithelial tumors of the brain—A review of surgical outcomes across several studies
Ranger, A. M., & Diosy, D. C. (2015) · Child s Nervous System · doi:10.1007/s00381-015-2675-9 · Cited by 57
Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)
Korczyn, A. D., Schachter, S. C., Brodie, M. J., Dalal, S. S., Engel, J., Guekht, A. B., Hečimović, H., Jerbi, K., Kanner, A. M., Landmark, C. J., et al. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.03.012 · Cited by 57
Self-citation
Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet
Lauritzen, F., Eid, T., & Bergersen, L. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0672-x · Cited by 59
Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry
Herzog, A. G., Mandle, H. B., Cahill, K. E., Fowler, K. M., Hauser, W. A., & Davis, A. R. (2016) · Epilepsia · doi:10.1111/epi.13320 · Cited by 57
A Comparison of Machine Learning Classifiers for Energy-Efficient Implementation of Seizure Detection
Manzouri, F., Heller, S., Dümpelmann, M., Woias, P., & Schulze‐Bonhage, A. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00043 · Cited by 57
Efficacy and Safety of Treatment with Transcutaneous Vagus Nerve Stimulation in 17 Patients with Refractory Epilepsy Evaluated by Electroencephalogram, Seizure Frequency, and Quality of Life
Liu, A., Rong, P., Gong, L., Song, L., Wang, X., Li, L., & Wang, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.910689 · Cited by 57
Discovery of [1,2,4]-triazolo [1,5-a]pyrimidine-7(4H)-one derivatives as positive modulators of GABAA1 receptor with potent anticonvulsant activity and low toxicity
Huang, L., Ding, J., Li, M., Hou, Z., Geng, Y., Li, X., & Yu, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111824 · Cited by 57
Why we urgently need improved epilepsy therapies for adult patients
Billakota, S., Devinsky, O., & Kim, K.-W. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107855 · Cited by 56
The biopsychosocial model and quality of life in persons with active epilepsy
Elliott, J. O., & Richardson, V. E. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.09.035 · Cited by 56
Outcome of corpus callosotomy in adults
Park, M. S., Nakagawa, E., Schoenberg, M. R., Benbadis, S. R., & Vale, F. Ĺ. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.04.015 · Cited by 56
What predicts enduring intractability in children who appear medically intractable in the first 2 years after diagnosis?
Wirrell, E. C., Wong‐Kisiel, L. C., Mandrekar, J. N., & Nickels, K. C. (2013) · Epilepsia · doi:10.1111/epi.12169 · Cited by 56
Continuing Burden of Refractory Epilepsy
Janson, M. T., & Bainbridge, J. L. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020948056 · Cited by 56
Psychological trajectories in the year after a newly diagnosed seizure
Velissaris, S. L., Saling, M. M., Newton, M. R., Berkovic, S. F., & Wilson, S. J. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03658.x · Cited by 56
Defining the Pharmacologically Intractable Headache for Clinical Trials and Clinical Practice
Silberstein, S. D., Dodick, D. W., & Pearlman, S. H. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01764.x · Cited by 56
TMS, cortical excitability and epilepsy: The clinical impact
Badawy, R. A. B., Strigaro, G., & Cantello, R. M. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.11.014 · Cited by 57
Surgical management of epilepsy
Jetté, N., Reid, A. Y., & Wiebe, S. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.121291 · Cited by 56
Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
Oakley, J. C., Cho, A. R., Cheah, C. S., Scheuer, T., & Catterall, W. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203331 · Cited by 56
Distinguishing language and race disparities in epilepsy surgery
Betjemann, J. P., Thompson, A. C., Santos‐Sánchez, C., Garcia, P. A., & Ivey, S. L. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.06.020 · Cited by 56
Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany
Strzelczyk, A., Haag, A., Reese, J. P., Nickolay, T., Oertel, W. H., Dodel, R. C., Knake, S., Rosenow, F., & Hamer, H. M. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.03.007 · Cited by 56
Complete remission in nonsyndromic childhood‐onset epilepsy
Berg, A. T., Testa, F. M., & Levy, S. R. (2011) · Annals of Neurology · doi:10.1002/ana.22461 · Cited by 56
Turning down the volume: Astrocyte volume change in the generation and termination of epileptic seizures
Murphy, T. R., Binder, D. K., & Fiacco, T. A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.016 · Cited by 59
The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)
Ross, E. E., Stoyell, S. M., Kramer, M., Berg, A. T., & Chu, C. J. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.038 · Cited by 56
Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
Strzelczyk, A., Klein, K. M., Willems, L. M., Rosenow, F., & Bauer, S. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1156529 · Cited by 56
The LAM-SAFE Study: Lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults
Steinhoff, B. J., Ueberall, M. A., Siemes, H., Kurlemann, G., Schmitz, B., & Bergmann, L. (2005) · Seizure · doi:10.1016/j.seizure.2005.09.011 · Cited by 56
Synergistic Combinations of Anticonvulsant Agents: What Is the Evidence from Animal Experiments?
Jonker, D. M., Voskuyl, R. A., & Danhof, M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00952.x · Cited by 56
Understanding the patient with epilepsy and seizures in the dental practice.
Aragon, C. E., & Burneo, J. G. (2007) · PubMed · Cited by 56
How to Explain Multidrug Resistance in Epilepsy?
Löscher, W. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2005.05311.x · Cited by 56
Comprehensive care of the epilepsy patient—control, comorbidity, and cost
W. Bazil, C. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.455002.x · Cited by 55
A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence
Pakpour, A. H., Gholami, M., Esmaeili, R., Naghibi, S. A., Updegraff, J. A., Molloy, G. J., & Dombrowski, S. U. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.08.036 · Cited by 55
Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore
Kong, S. T., Ho, C. S., Ho, P. C., & Lim, S.-H. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.05.005 · Cited by 55
Case Report: Responsive Neurostimulation of the Centromedian Thalamic Nucleus for the Detection and Treatment of Seizures in Pediatric Primary Generalized Epilepsy
Welch, W. P., Hect, J. L., & Abel, T. J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.656585 · Cited by 56
Intracranial neuromodulation with deep brain stimulation and responsive neurostimulation in children with drug-resistant epilepsy: a systematic review
Khan, M., Paktiawal, J., Piper, R. J., Chari, A., & Tisdall, M. M. (2021) · Journal of Neurosurgery Pediatrics · doi:10.3171/2021.8.peds21201 · Cited by 56
Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
Makridis, K. L., Bast, T., Prager, C., Kovacevic-Preradovic, T., Bittigau, P., Mayer, T., Breuer, E., & Kaindl, A. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.950171 · Cited by 55
“, treatment with two or more correctly chosen and dosed anti-seizure medications (ASMs) does not achieve seizure freedom (2).”
Stem cells as a potential therapy for epilepsy
Roper, S. N., & Steindler, D. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.004 · Cited by 55
Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy
Gavatha, M., Ioannou, I., & Papavasiliou, A. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.02.005 · Cited by 55
Animal model studies application to human patients
Holmes, G. L. (2007) · Neurology · doi:10.1212/01.wnl.0000302369.24230.c6 · Cited by 55
Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma
Li, H., Graber, K., Jin, S., McDonald, W. S., Barres, B. A., & Prince, D. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.019 · Cited by 56
Chronic subthreshold subdural cortical stimulation for the treatment of focal epilepsy originating from eloquent cortex
Child, N. D., Stead, M., Wirrell, E. C., Nickels, K. C., Wetjen, N. M., Lee, K. H., & Klassen, B. T. (2014) · Epilepsia · doi:10.1111/epi.12525 · Cited by 55
Synergism of lacosamide with established antiepileptic drugs in the 6‐ H z seizure model in mice
Shandra, A. A., Shandra, P., Каshchenko, О. А., Matagne, A., & Stöhr, T. (2013) · Epilepsia · doi:10.1111/epi.12237 · Cited by 55
1,2,4-Triazole Derivatives as Potential Scaffold for Anticonvulsant Activity
Kamboj, V. K., Verma, P. K., Dhanda, A., & Ranjan, S. (2015) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524915666150209100533 · Cited by 55
Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery
Vale, F. Ĺ., Ahmadian, A. A., Youssef, A. S., Tatum, W. O., & Benbadis, S. R. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.003 · Cited by 53
Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
Nabukenya, A. M., Matovu, J. K. B., Wabwire‐Mangen, F., Wanyenze, R. K., & Makumbi, F. E. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-49 · Cited by 55
Comparative efficacy of combination drug therapy in refractory epilepsy
Poolos, N. P., Warner, L. N., Humphreys, S. Z., & Williams, S. P. (2011) · Neurology · doi:10.1212/wnl.0b013e31823ed0dd · Cited by 55
Chemogenetic silencing of the midline and intralaminar thalamus blocks amygdala-kindled seizures
Wicker, E., & Forcelli, P. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.003 · Cited by 55
Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
Grewal, G. K., Kukal, S., Kanojia, N., Saso, L., Kukreti, S., & Kukreti, R. (2017) · Molecules · doi:10.3390/molecules22030365 · Cited by 59
Neuroimaging in Epilepsy
Middlebrooks, E. H., Hoef, L. V., & Szaflarski, J. P. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0746-x · Cited by 56
Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy
Xu, C., Wang, Y., Zhang, S., Nao, J., Liu, Y., Wang, Y., Ding, F., Zhong, K., Chen, L., Ying, X., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25554 · Cited by 56
Potent anti-seizure effects of D-leucine
Hartman, A. L., Santos, P. T., O’Riordan, K. J., Stafstrom, C. E., & Hardwick, J. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.013 · Cited by 54
Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy
Łuszczki, J. J., & Czuczwar, S. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.020 · Cited by 55
Outcome patterns in epilepsy surgery—the long-term view
Wiebe, S. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.9 · Cited by 54
Multistable dynamics in a Hopfield neural network under electromagnetic radiation and dual bias currents
Wan, Q., Yan, Z., Li, F., Liu, J., & Chen, S. (2022) · Nonlinear Dynamics · doi:10.1007/s11071-022-07544-x · Cited by 54
“[26] firstly studied a small Hopfield neural network with three neurons, which found that periodic motion and chaotic motion appeared intermittently with variations in some system parameters, and this may explain the intermittent convulsions in patients with Epilepsy [27, 28].”
Background
Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders
Anwar, M. J., Alenezi, S. K., & Alhowail, A. H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114718 · Cited by 60
Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States
Ivanova, J. I., Birnbaum, H. G., Kidolezi, Y., Qiu, Y., Mallett, D. A., & Caleo, S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02422.x · Cited by 54
The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
Hartman, A. L., Santos, P. T., Dolce, A. M., & Hardwick, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045156 · Cited by 54
Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis
Yuen, A. W. C., & Sander, J. W. A. S. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.004 · Cited by 54
A connectomics approach combining structural and effective connectivity assessed by intracranial electrical stimulation
Donos, C., Mălîia, M. D., Mı̂ndruță, I., Popa, I., Ene, M., Bălănescu, B., Ciurea, A., & Barborică, A. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.054 · Cited by 55
Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model
Vieira, V., Glassmann, D., Marafon, P., Pereira, P., Gomez, R., & Coitinho, A. S. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.08.020 · Cited by 54
The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy
Pottoo, F., Tabassum, N., Javed, M. N., Nigar, S., Rasheed, R., Khan, A., Barkat, M., Alam, M. S., Maqbool, A., Ansari, M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1121-x · Cited by 39
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy
Thompson, M. D., Martin, R. C., Grayson, L. E., Ampah, S. B., Cutter, G., Szaflarski, J. P., & Bebin, E. M. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107299 · Cited by 58
Role of ictal baseline shifts and ictal high‐frequency oscillations in stereo‐electroencephalography analysis of mesial temporal lobe seizures
Wu, S., Veedu, H. P. K., Lhatoo, S. D., Koubeissi, M. Z., Miller, J. P., & Lüders, H. O. (2014) · Epilepsia · doi:10.1111/epi.12608 · Cited by 53
Comparison of seizure control outcomes and the safety of vagus nerve, thalamic deep brain, and responsive neurostimulation: evidence from randomized controlled trials
Rolston, J. D., Englot, D. J., Wang, D. D., Shih, T., & Chang, E. F. (2012) · Neurosurgical FOCUS · doi:10.3171/2012.1.focus11335 · Cited by 53
MRI-negative refractory partial epilepsy: Role for diffusion tensor imaging in high field MRI
Chen, Q., Lui, S., Li, C., Jiang, L., Ouyang, L., Tang, H., Shang, H., Huang, X., Gong, Q., & Zhou, D. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.03.009 · Cited by 53
Surgical Treatment of Epilepsy
Miller, J. W., & Hakimian, S. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000431398.69594.97 · Cited by 53
Sleep-related hypermotor epilepsy
Licchetta, L., Bisulli, F., Vignatelli, L., Zenesini, C., Vito, L. D., Mostacci, B., Rinaldi, C., Trippi, I., Naldi, I., Plazzi, G., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003459 · Cited by 53
Neurostimulation Devices Used in Treatment of Epilepsy
Dalkilic, E. B. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0442-9 · Cited by 53
Epilepsy, antiepileptic drugs, and serious transport accidents
Sundelin, H. E. K., Chang, Z., Larsson, H., Lichtenstein, P., Almqvist, C., Tomson, T., & Ludvigsson, J. F. (2018) · Neurology · doi:10.1212/wnl.0000000000005210 · Cited by 53
Emergency hospital care for adults with suspected seizures in the NHS in England 2007–2013: a cross-sectional study
Dickson, J. M., Jacques, R., Reuber, M., Hick, J., Campbell, M. J., Morley, R., & Grünewald, R. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023352 · Cited by 53
Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis
Reis, R. D. C., Almeida, K. J., Lopes, L. D. S., Mendes, C. M. D. M., & Bor‐Seng‐Shu, E. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106635 · Cited by 57
Use of complementary and alternative medicine in epilepsy
Ricotti, V., & Delanty, N. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-006-0029-4 · Cited by 53
Chronic Sorrow and Coping in Families of Children with Epilepsy
Hobdell, E. F., Grant, M., Valencia, I., Mare, J., Kothare, S. V., Legido, A., & Khurana, D. S. (2007) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200704000-00003 · Cited by 53
Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures
Miller, R. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00049-3 · Cited by 53
Synchrony Levels During Evoked Seizure-Like Bursts in Mouse Neocortical Slices
van Drongelen, W., Koch, H., Marcuccilli, C. J., Peña‐Ortega, F., & Ramirez, J. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00392.2003 · Cited by 53
Interrater reliability of the international consensus definition of drug-resistant epilepsy: A pilot study
Hao, X.-T., Wong, I. S. M., & Kwan, P. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.06.035 · Cited by 52
Self-citation
Anterior nucleus of the thalamus seizure detection in ambulatory humans
Gregg, N. M., Marks, V. S., Sladky, V., Lundstrom, B. N., Klassen, B. T., Messina, S. A., Brinkmann, B. H., Miller, K. J., Gompel, J. J. V., Křemen, V., et al. (2021) · Epilepsia · doi:10.1111/epi.17047 · Cited by 52
Caregiving in pediatric epilepsy: Results of focus groups and implications for research and practice
Smith, G. M., Wagner, J. L., Andrews, J. A., AUSTIN, J. K., Mueller, M., Carter, E., & Griesemer, K. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.03.002 · Cited by 52
Environmental enrichment: Evidence for an unexpected therapeutic influence
Kotloski, R. J., & Sutula, T. P. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.11.012 · Cited by 54
Neurostimulation for Drug-Resistant Epilepsy
DeGiorgio, C. M., & Krahl, S. E. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000431397.61970.2b · Cited by 52
Anticonvulsant effects of the selective melatonin receptor agonist ramelteon
Fenoglio, K. A., Mazarati, A. M., Sefidvash-Hockley, S., Shin, D. H., Wilke, J. C., Milligan, H. L., Sankar, R., Rho, J. M., & Maganti, R. K. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.07.022 · Cited by 52
The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational study
Werhahn, K. J., Klimpe, S., Balkaya, S., Trinka, E., & Krämer, G. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.015 · Cited by 52
An Automatic Prediction of Epileptic Seizures Using Cloud Computing and Wireless Sensor Networks
Sareen, S., Sood, S. K., & Gupta, S. K. (2016) · Journal of Medical Systems · doi:10.1007/s10916-016-0579-1 · Cited by 52
Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies
Łukawski, K., Andres‐Mach, M., Czuczwar, M., Łuszczki, J. J., Kruszyński, K., & Czuczwar, S. J. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.07.012 · Cited by 57
Automated Online Quantification Method for 18F-FDG Positron Emission Tomography/CT Improves Detection of the Epileptogenic Zone in Patients with Pharmacoresistant Epilepsy
Coelho, V. C. M., Morita, M. E., Amorim, B. J., Ramos, C. D., Yasuda, C. L., Tedeschi, H., Ghizoni, E., & Cendes, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00453 · Cited by 52
Behavioral interventions as a treatment for epilepsy
Haut, S. R., Lipton, R. B., Cornes, S. B., Dwivedi, A. K., Wasson, R. S., Cotton, S., Strawn, J. R., & Privitera, M. (2018) · Neurology · doi:10.1212/wnl.0000000000005109 · Cited by 52
Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature
Willems, L. M., Reif, P. S., Spyrantis, A., Cattani, A., Freiman, T. M., Seifert, V., Wagner, M., You, S.-J., Schubert‐Bast, S., Bauer, S., et al. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.012 · Cited by 52
Identification and Treatment of Drug-Resistant Epilepsy
Yoo, J. Y., & Panov, F. E. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000710 · Cited by 52
Gabapentin dosing in the treatment of epilepsy
McLean, M. J., & Gidal, B. E. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80127-3 · Cited by 52
Impact of CYP2C19 Polymorphisms on the Efficacy of Clobazam Therapy
Seo, T., Nagata, R., Ishitsu, T., Murata, T., Takaishi, C., Hori, M., & Nakagawa, K. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.527 · Cited by 52
Gene-Wide Tagging Study Of Association BetweenABCB1Polymorphisms and Multidrug Resistance in Epilepsy in Han Chinese
Kwan, P., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Poon, W. S., Ng, H., Wong, K. S., & Baum, L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.32 · Cited by 52
Self-citation
Unpredictability of Seizures and the Burden of Epilepsy
Schulze‐Bonhage, A., & Kühn, A. (2008) · Wiley eBooks · doi:10.1002/9783527625192.ch1 · Cited by 52
Human clinical trails in antiepileptogenesis
Mani, R., Pollard, J., & Dichter, M. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.010 · Cited by 51

Authors: Kwan, P., & Brodie, M. J.
Affiliations: Western Infirmary (GB)
ORCID: Kwan, Patrick
Brodie, Martin J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-02-03
Volume: 342
Issue: 5
Pages: 314-319
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200002033420503
OpenAlex: W1974809694
Cited by: 5,204
References: 39
Citations by year: 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
FWCI: 55.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
CRC Press eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords: drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Identification of Refractory Epilepsy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks